HEALTH CARE UTILIZATION AND COSTS

PUBLICATIONS

Factors Associated with the Initiation of Biologic Disease Modifying Antirheumatic Drugs in Texas Medicaid Patients with Rheumatoid Arthritis 
           Authors: Kim G, Barner JC, Rascati K, Richards K
           Journal of Managed Care & Specialty Pharmacy 2015;21(5):401-407

Health Costs and Outcomes associated with Medicare Part D Prescription Drug Cost-Sharing in Beneficiaries on Dialysis 
           Authors: Park H, Rascati KL, Lawson KA, Barner JC, Richards KM, Malone DC
           Journal of Managed Care & Specialty Pharmacy 2015;21(10):956-964

Patterns of Specific Testing for Patients with Chronic Myelogenous Leukemia
           Authors: Bell AM, Richards KM, Frei CR, Koeller JM
           American Journal of Pharmacy Benefits 2015;7(6):e147-152.

PRESENTATIONS

Medical Resource Utilization and Expenditures by Disease-Modifying Therapy Adherence and Non-Adherence in Texas Medicaid Patients with Multiple Sclerosis
           Authors: Richards KM, Ko JJ, Yu T-C, Nazareth T, Lawson KA
           Academy of Managed Care Pharmacy Nexus Meeting; National Harbor, MD; October 2016

Burden of Preterm Labor in the Texas Medicaid Population
           Authors: Richards KM, Troeger K, Petrilla A, Agatep B, Johnsrud M, Blackwell S
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; Washington, DC; May 2016

Time-to-Initiation, Healthcare Utilization, and Costs of Treatment of Attention Deficit Hyperactivity Disorder among Texas Medicaid Preschoolers
           Authors: Singh RR, Lawson KA, Barner JC, Richards KM, Sasane R, Wilson JP
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; Washington, DC; May 2016

Healthcare Utilization and Costs Associated with Potential Refractory Epilepsy in Texas Medicaid
           Authors: Gupte-Singh K, Barner JC, Wilson JP, Hovinga CA, Richards KM, Rascati KL
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; Washington, DC; May 2016

Differences in Patient Characteristics, Disease-Modifying Treatment Utilization, and Relapse by Race/Ethnicity in Texas Medicaid Patients with Multiple Sclerosis
           Authors: Richards KM, Lawson KA, Nazareth T, Yu T-C, Ko JJ, Burton E, Sasane R
           Congress of the European Committee for Treatment and Research in Multiple Sclerosis; Barcelona, Spain; October 2015

Prescribing Patterns and Expenditures for Otitis Media-Related Antibiotics for Children in the Texas Medicaid Program
           Authors: Ma X, Lawson KA, Richards KM
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; Montreal, Canada; June 2014

Persistent Otitis Media among Texas Medicaid Children – Prevalence and Healthcare Utilization and Costs
           Authors: Richards KM, Lawson KA, Nwokeji ED, Ma X
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; Montreal, Canada; June 2014

Acute Care Utilization in Patients with Epilepsy on Antiepileptic Monotherapy
           Authors: Shcherbakova N, Rascati KL, Brown CM, Lawson K, Richards K, Novak S, Yoder L
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; New Orleans, LA; May 2013

Burden of Schizophrenia in Texas
           Authors: Rascati KL, Lawson K, Richards K, Desai P, Miller A
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; New Orleans, LA; May 2013

Indirect Costs of Schizophrenia for Community-Dwelling Texas Residents
           Authors: Desai P, Lawson K, Rascati KL, Richards K
           International Society for Pharmacoeconomics and Outcomes Research Annual Meeting; New Orleans, LA; May 2013


Facebook link icon

Make a Gift
Texas Pharmacy: The University of Texas at Austin College of Pharmacy